Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and/or ribavirin

被引:16
作者
Watanabe, Takuya [1 ]
Hirono, Haruka [1 ]
Hasegawa, Katsuhiko [1 ]
Soga, Kenji [1 ]
Shibasaki, Koichi [1 ]
机构
[1] Nippon Dent Univ, Sch Life Dent Niigata, Dept Internal Med & Gastroenterol, Hosp Med,Chuo Ku, Niigata 9518580, Japan
关键词
adverse reaction; interferon; literature review; ribavirin; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; CHRONIC HEPATITIS-C; COMBINATION THERAPY; MULTIPLE-SCLEROSIS; ALPHA THERAPY; PATIENT;
D O I
10.1111/j.1440-1746.2011.06890.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Ulcerative colitis (UC) is an immune disorder of the gastrointestinal tract which has been reported to be precipitated by interferon (IFN) therapy. We describe the results of a literature review of cases in which the development or exacerbation of UC was coincident with IFN and/or ribavirin (RIB) treatment for chronic hepatitis C. We summarized the studies on the effectiveness of IFN for UC or Crohn's disease, which were primarily carried out in Europe and the USA.
引用
收藏
页码:1709 / 1716
页数:8
相关论文
共 46 条
[1]
Asakura H, 1993, Nihon Naika Gakkai Zasshi, V82, P656
[2]
Prevalence of ulcerative colitis and Crohn's disease in Japan [J].
Asakura, Keiko ;
Nishiwaki, Yuji ;
Inoue, Nagamu ;
Hibi, Toshifumi ;
Watanabe, Mamoru ;
Takebayashi, Toru .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) :659-665
[3]
Awakawa Teruhito, 2003, Nihon Shokakibyo Gakkai Zasshi, V100, P680
[4]
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study [J].
Bargiggia, S ;
Thorburn, D ;
Anderloni, A ;
Ardizzone, S ;
Giorgi, A ;
Porro, GB ;
Parente, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) :209-215
[5]
Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283
[6]
CAPOBIANCHI MR, 1992, CLIN EXP IMMUNOL, V90, P85
[7]
The addition of ribavirin to interferon-α therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism [J].
Carella, C ;
Mazziotti, G ;
Morisco, F ;
Rotondi, M ;
Cioffi, M ;
Tuccillo, C ;
Sorvillo, F ;
Caporaso, N ;
Amato, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (06) :743-749
[8]
Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002 [J].
Cohen, Russell ;
Robinson, Don, Jr. ;
Paramore, Clark ;
Fraeman, Kathy ;
Renahan, Kevin ;
Bala, Mohan .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (06) :738-743
[9]
COTTONE M, 1995, ITAL J GASTROENTEROL, V27, P3
[10]
ERIK L, 2008, CYTOKINE, V41, P84